- Home
- AIRG vs ALXO Comparison
AIRG vs ALXO Comparison
Compare AIRG & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- ALXO
- Stock Information
- Founded
- AIRG 1995
- ALXO 2015
- Country
- AIRG United States
- ALXO United States
- Employees
- AIRG 121
- ALXO N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- ALXO Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- ALXO Health Care
- Exchange
- AIRG Nasdaq
- ALXO Nasdaq
- Market Cap
- AIRG 39.4M
- ALXO 76.5M
- IPO Year
- AIRG 2016
- ALXO 2020
- Fundamental
- Price
- AIRG $3.59
- ALXO $0.55
- Analyst Decision
- AIRG Strong Buy
- ALXO Strong Buy
- Analyst Count
- AIRG 2
- ALXO 6
- Target Price
- AIRG $10.25
- ALXO $4.14
- AVG Volume (30 Days)
- AIRG 22.1K
- ALXO 529.8K
- Earning Date
- AIRG 05-07-2025
- ALXO 05-08-2025
- Dividend Yield
- AIRG N/A
- ALXO N/A
- EPS Growth
- AIRG N/A
- ALXO N/A
- EPS
- AIRG N/A
- ALXO N/A
- Revenue
- AIRG $60,599,000.00
- ALXO N/A
- Revenue This Year
- AIRG $1.27
- ALXO N/A
- Revenue Next Year
- AIRG $33.13
- ALXO N/A
- P/E Ratio
- AIRG N/A
- ALXO N/A
- Revenue Growth
- AIRG 8.13
- ALXO N/A
- 52 Week Low
- AIRG $3.17
- ALXO $0.46
- 52 Week High
- AIRG $10.34
- ALXO $17.83
- Technical
- Relative Strength Index (RSI)
- AIRG 40.83
- ALXO 37.26
- Support Level
- AIRG $3.40
- ALXO $0.46
- Resistance Level
- AIRG $4.10
- ALXO $0.63
- Average True Range (ATR)
- AIRG 0.37
- ALXO 0.06
- MACD
- AIRG 0.10
- ALXO 0.02
- Stochastic Oscillator
- AIRG 45.36
- ALXO 42.86
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.